PRLR and obesity disorder: This is also true for Prolactin receptor and TCK1 (Creatine kinase, testis isozyme), two other molecules suppressed by NP-6A4 treatment since their roles in cardiac functions in conditions of untreated obesity and pre-diabetes are not known.